CKPT SHAREHOLDER ALERT: ROSEN, LEADING TRIAL ATTORNEYS, Encourages Checkpoint Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – CKPT

NEW YORK--(BUSINESS WIRE)---- $CKPT #CKPT--WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Checkpoint Therapeutics, Inc. (NASDAQ: CKPT) between March 10, 2021 and December 15, 2023, both dates inclusive (the “Class Period”), of the important June 4, 2024 lead plaintiff deadline. SO WHAT: If you purchased Checkpoint securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrang